Further mechanistic investigations determined that the elevation of intracellular GSSG levels resulted in NF-B inhibition by facilitating glutathionylated IKK- (IKK--SSG) formation, leading to enhanced TNF hepatotoxicity
DSIP was well tolerated in all published clinical trials, with a tolerability rate of 97%
Evidence is limited, but precaution is warranted for individuals on multiple medications
Limited research on side effects : Few studies have explored BPC 157's potential negative effects, and its full range of effects is not well understood
What does the blue color indicate about the products potency
Clinical evidence : a 2020 study by Li et al., demonstrated that time-restricted eating altered the gut microbiota composition in overweight adults, leading to improved metabolic outcomes (Li et al., 2020)